Daiichi Sankyo Begins Phase 3 Study For Edoxaban

Daiichi Sankyo announced that it has initiated enrollment of patients into the multinational Phase III study ENSURE-AF evaluating the safety and efficacy of edoxaban against enoxaparin and warfarin.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news